We are delighted to announce that have just started our work with RTI International on a new piece of work that will quantify the cost of #ovariancancer on society. As a companion to the Every Woman Study™, it is hoped that this critical piece of work will solidify the case for urgent change. The Coalition will look at the economic and societal costs of ovarian cancer in 11 countries, representing high- to low-income settings. This Study will also shed light on the impact that positive changes to diagnosis and treatment of the disease could make. Our goal is to show that getting to #NoWomanLeftBehind is not only a moral imperative, but a financial one as well.
Results expected in early 2024.